Pharmaceutical preparations containing desogestrel and etonogestrel: risk of meningioma and new risk minimization measures,
Litfulo (ritlesitinib): product information update to align warnings with those of other Janus kinase inhibitors
For the full text of the announcement click here.
For the text, as published on the website of the European Medicines Agency (EMA), please visit://www.ema.europa.eu/
